Skip to main content
# Title Research Member Research Year
71 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Prof. Eman Massad Zaki El-Hefny 2019
72 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Dr. Asmaa Mohamed Zahran Omar 2019
73 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Dr. Asmaa Mohamed Zahran Omar 2019
74 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Dr. Asmaa Mohamed Zahran Omar 2019
75 Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia
Prof. Hosny Badrawy Hamed Omran 2019
76 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients Dr. Iman Hassan Ahmed Hamada 2019
77 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Asmaa Ahmed Mohamed ahmed 2019
78 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Prof. Eman Massad Zaki El-Hefny 2019
79 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Dr. Asmaa Mohamed Zahran Omar 2019
80 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Prof. Eman Massad Zaki El-Hefny 2019